full in Biological Technology
Navigation Links
full in Biological Technology
Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters
SAN DIEGO, July 24 /PRNewswire-FirstCall/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) today announced that its underwriters fully exercised their overallotment option to purchase an additional 1,500,000 shares of its common stock in connection with its previously announced public of...ST. LOUIS, July 23 /PRNewswire-FirstCall/ --Sigma-Aldrich Corporation (Nasdaq: SIAL ), a leading Life Science and High Technology company, reported second quarter 2009 diluted EPS of $0.68 compared to $0.70 in the second quarter of 2008. For the six months ended June 30, 2009, reporte...
China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
SHANGHAI, July 15 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced its financial results for t...SHANGHAI, July 10 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the research, development, manufacture, marketing and distribution of probiotics dietary supplements, today announced it will host a c...
Many medical device makers have older products, with old yet still functional software code bases. In this Software Technology Report, Full Spectrum Software offers a guide to updating documentation for existing code and creating the software specifications to write new modern software for your m...
Spherix Regains Full NASDAQ Compliance
BETHESDA, Md., May 22 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX ), an innovator in biotechnology for diabetes therapy and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it has ful...Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
PRINCETON, N.J., April 29 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today reported earnings for its first quarter ended March 31, 2009 of $0.63 per diluted share versus $0.76 per diluted share in the first quarter of 2008 (or $0.73 per diluted share after excluding the centralized ECG ...Wyeth Announces Full Redemption of $2 Convertible Preferred Stock
MADISON, N.J., April 23 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) announced today that it will fully redeem all of its outstanding $2 Convertible Preferred Stock, par value $2.50 per share (the "Convertible Preferred Stock") effective on July 15, 2009 (the "Redemption Date"). As of April 22,...China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results
CHANGCHUN, China and LOS ANGELES, April 23 /PRNewswire-Asia-FirstCall/ -- - Fourth Quarter 2008 Revenue Increased 28.6% to $14.1 Million, with Net Income was $0.9 Million and Diluted EPS of $.03 - 2008 Revenues Increased 23.5% to $59.1 Million vs. 2007 - 2008 Gross Profit ...The Importance of Mixing: How to Compare Lab Scale Mixing with Full Scale Process Vessel Performance
This free Importance of Mixing webinar will compare lab mixing and large scale mixing, and features excerpts from two short courses given by Reinaldo M. Machado entitled "Fundamentals of Scale-up" and "iControl Mixing Guidelines". Columbia, MD (PRWEB...Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables
BEIJING, April 9 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA ), a leading developer and provider of vaccines in China, today announced the Company's unaudited financial results for the three and twelve month periods ended December 31, 2008. Full Year 2008 Financial High...Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
BEIJING, April 9 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA ), a leading developer and provider of vaccines in China, today announced the Company's unaudited financial results for the three and twelve month periods ended December 31, 2008. Full Year 2008 Financial High...US Oncology Provides Full Service Management of Clinical Trials
HOUSTON, April 2 /PRNewswire/ -- US Oncology , the nation's foremost cancer treatment and research network, has established US Oncology Clinical Development (USOCD), a full service contract research organization (CRO). USOCD formalizes many of the services that US Oncology Resear...NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
2008 and Recent Events Highlighted EMERYVILLE, Calif., April 1, /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY ), a mid-stage biopharmaceutical company developing first-in-class anti-infective products for the treatment and prevention of a wide range of infections w...Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2008 Financial Results
BEIJING, April 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Amex: SVA ), a leading provider of vaccines in China, today announced that it will host a conference call on Thursday, April 9, 2009 at 9:00 a.m. ET (9 p.m. China Standard Time) to review the Company's financial results for the four...BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results
LYNBROOK, N.Y., March 30 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2008. "We are ...TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results
LA JOLLA, Calif., March 27 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced financial results for the fourth quarter and year ended December 31, 2008. For the full year 2008, the Company posted revenue of $6.1 million and a net loss of $22.8 million. Cash and ca...ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today reported financial results for the fourth quarter and year ended December 31, 2008. "2008 was a transition year for ADVENTRX in which we advanced a new business model focused on lower-risk r...Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor
Success in Limited Market Release Hospitals Highlights Early Clinical Benefits and Patient Impact IRVINE, Calif., March 24 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI ), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today th...BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results
PLYMOUTH MEETING, Pa., March 17 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP ) ("BMP Sunstone" or the "Company"), today announced financial results for the fourth quarter and fiscal year ended December 31, 2008. Financial Highlights as of December 31, 2008: ...ThromboGenics Announces Business Update and 2008 Full Year Results
LEUVEN, Belgium, March 12 /PRNewswire-FirstCall/ -- - ThromboGenics Reports Pre-Tax Profit of EUR12.2 Million For 2008 ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments that will make a real differ...Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
- Year end cash position improved through non core divestitures - - Caliper signs extension of $25 million credit facility through November 2010 - - Non-cash restructuring and goodwill impairment charge of $45.3 million recognized - HOPKINTON, Mass., March 12 /PRNewswire-FirstCall...BETHESDA, Md., March 12 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it is regaining from its partner MedImmune the rights in ...
Oncothyreon reports full year and fourth quarter 2008 financial results
SEATTLE, March 9 /PRNewswire-FirstCall/ - Oncothyreon Inc. (NASDAQ: ONTY ) (TSX: ONY) (the "Company") today reported financial results for the year and quarter ended December 31, 2008. Net income for the year ended December 31, 2008 was $7.1 million, or $0.37 per basic and $0.36 per diluted sh...SAN FRANCISCO, March 9 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a leading company in the development of novel therapeutics for heart failure patients, today announced its fourth quarter and full year financial results for 2008 and will host a conference call and live ...
GRRL Tech Participant Offered Full Tuition Four-Year Scholarship to Roger Williams University
Expo Concludes with Announcement of RWU Scholarship Award to Middletown High School Sophomore BRISTOL, R.I., March 6 /PRNewswire-USNewswire/ -- As part of an ongoing commitment of encouraging young women to pursue careers in science and technology, Roger Williams University today announce...SAN DIEGO, March 5 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today announced that it will release its f...
NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
FT. MYERS, Fla., March 5 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin Board: NGNM), an operator of a network of cancer-focused testing laboratories, today announced its results for the fourth quarter and full-year ended December 31, 2008. Fourth Quarter 2008 Highlights...EATONTOWN, N.J., March 4 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field of biologic products for regenerative healing, today reported financial results for the fourth quarter and full year ended December 31, 2008. "The last twelve months were an im...
Mindray Announces 2008 Fourth Quarter and Full Year Results
SHENZHEN, China, March 4 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the fourth quarter and full year ended December ...STAAR Surgical Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call
MONROVIA, Calif., March 4 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA ) today announced that it will release financial results for the fourth quarter and full year ended January 2, 2009 on Monday, March 16, 2009 after the market close. The Company will host a conference ...NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009
FT. MYERS, Fla., March 3 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM ) announced today that it plans to release its fourth quarter and full year 2008 financial results on Thursday March 5, 2009. The Company has scheduled a webcast and conference call to discuss th...NANJING, China, March 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR ), a leading manufacturer and supplier of branded generic pharmaceuticals and innovative anti-cancer pharmaceuticals in the rapidly growing China market, announced today that it intends to release its 2008 f...
ERT Reports Fourth Quarter and Full Year 2008 Results
Q4 2008 Net Revenues - $30.1 million vs. $28.9 million in Q4 2007 - a 4.0% increase Q4 2008 Diluted Net Income per Share - $0.11 vs. $0.10 in Q4 2007 - a 10.0% increase Q4 2008 New Bookings of $45.1 million vs. $39.2 million in Q4 2007 - a 15.1% increase 2008 Net Revenues -- $133.1...InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
BRISBANE, Calif., Feb. 26 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced results from operations for the fourth quarter and 12 months ended December 31, 2008. InterMune reported a net loss for the fourth quarter of 2008 of $32.3 million, or $0.83 per share, compar...SOPHIA ANTIPOLIS, France, February 26 /PRNewswire-FirstCall/ -- NicOx S.A. (NYSE Euronext Paris: COX) today announced its financial results for full year 2008 and provided an overview of the development and pre-commercialization activities for naproxcinod, its lead investigational drug for the...
Arpida Announces Full Year 2008 Financial Results
REINACH, Switzerland, February 25 /PRNewswire-FirstCall/ -- Arpida Ltd (SIX: ARPN) announced today its financial results for the year ending 31 December 2008. 2008 Key Events - Setback in regulatory process for intravenous iclaprim in US - Restructuring and focus on iclapr...3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009
SHENYANG, China, Feb. 25 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX ), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release financial results for the fourth qu...ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
-- Quarter Highlighted by Cinryze(TM) [C1 Inhibitor (human)] Commercial Launch -- EXTON, Pa., Feb. 24 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) reported today its financial results for the fourth quarter and year ended December 31, 2008. Key events since Septemb...Amsterdam Molecular Therapeutics Reports Full Year Results 2008
AMSTERDAM, the Netherlands, February 24 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its results for the year of 2008. Highlights - Extra clinical trial in LPL deficiency causes a delay of th...Other TagsDMSOconcentratestainstainstainstainstainstainSYBRhomologAlpcoOther Contentsmonocotmonocytesmonocytesmonoecious
(Date:3/15/2010)... seabirds, cover enormous distances during migration: the sooty shearwater, ... times on its travels. Despite this, relatively little is ... with that of their land-living counterparts. Scientists from the ... behaviour of thin-billed prions and discovered that the animals ... at a considerable distance from each other. Thus, it ...
(Date:3/15/2010)... paradigm changing discovery, Plasmodium vivax ( P. ... historically thought to be resistant to the disease, those ... on their red blood cells, according to researchers from ... and the Madagascar Ministry of Health. In a study ... the main malaria transmission areas of Madagascar, the researchers ...
(Date:3/15/2010)... An experimental oral drug has lowered blood sugar levels ... that the medication could someday be added to the ... this disease, according to new research. , The drug ... activity of a protein called macrophage migration inhibitory factor, ... of diseases because it is associated with the production ...
Breaking Biology News(10 mins):To the Antarctic or Brazil for new feathers 2To the Antarctic or Brazil for new feathers 3Duffy-negative blood types no longer protected from P. Vivax malaria 2Duffy-negative blood types no longer protected from P. Vivax malaria 3Study points to potential new drug for type 2 diabetes 2Study points to potential new drug for type 2 diabetes 3Study points to potential new drug for type 2 diabetes 4Jet Powered Mobility Scooter Revolutionizes Mobility Transportation 64495 1Jet Powered Mobility Scooter Revolutionizes Mobility Transportation 64495 2Jet Powered Mobility Scooter Revolutionizes Mobility Transportation 64495 3Siemens Taps Top Energy Expert as New Head of U S Business 64492 1Siemens Taps Top Energy Expert as New Head of U S Business 64492 2Siemens Taps Top Energy Expert as New Head of U S Business 64492 3APDA Launches First of its Kind Parkinsons Rehab Resource Center 64489 1APDA Launches First of its Kind Parkinsons Rehab Resource Center 64489 2APDA Launches First of its Kind Parkinsons Rehab Resource Center 64489 3(Date:3/16/2010)... Will Connect Families with Uninsured Children to Non-Profit Agencies Assisting with Enrollment into State-Sponsored Health Coverage Programs , ... ... ... ... ST. PAUL, Minn. , March ...
(Date:3/16/2010)... the Superfruits Behind , ... Provo, UT (Vocus) March ... their flagship product will no longer be called Tahitian Noni® Juice, ... . Although the name is changing, Tahitian Noni Original is the ... people around the world for years. The name change comes from ...
(Date:3/16/2010)... Dr. Glen Elliott of Children’s Health Council leads clinical research for ... ... 16, 2010 -- Autism is an exceptionally complex illness. Autism ... in addition to restricted, repetitive behaviors. Once considered quite rare, ... diagnosed with the illness, making it a common developmental disability. ...
(Date:3/16/2010)... the best selling skin brightener, has now introduced anti aging ... complete skin care formula. , ... ... ingredients to make SkinBright the most complete skin brightener available. ... scars and uneven skin tone are fading into history with ...
(Date:3/16/2010)... (EDS) announces the introduction of the SafeSiders Glide Path ... effortless endodontic instrumentation, the SafeSiders glide path instruments are ... ... (PRWEB) March 16, 2010 ... of the SafeSiders Glide Path Kit. Designed specifically to ...
Breaking Medicine News(10 mins):Health News:Minnesota Coalition for Kids Health Coverage Launches HealthyKidsMN.org 2Health News:Minnesota Coalition for Kids Health Coverage Launches HealthyKidsMN.org 3Health News:Minnesota Coalition for Kids Health Coverage Launches HealthyKidsMN.org 4Health News:Minnesota Coalition for Kids Health Coverage Launches HealthyKidsMN.org 5Health News:Tahitian Noni Juice Is Now Tahitian Noni Original Bioactive Beverage 2Health News:Autism Research Study Announced By Children's Health Council 2Health News:Best Selling, Non Toxic Skin Brightener Does the Job Using Safe, Healthy Ingredients and Introduces New Anti Aging Ingredients 2[0] Minnesota Coalition for Kids Health Coverage Launches HealthyKidsMN.org[0] Tahitian Noni Juice Is Now Tahitian Noni Original Bioactive Beverage[0] Autism Research Study Announced By Children's Health Council [0] Best Selling, Non Toxic Skin Brightener Does the Job Using Safe, Healthy Ingredients and Introduces New Anti Aging Ingredients [0] EDS Announces New SafeSiders Endodontic Glide Path Kit
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |